share_log

Reviewing Definitive Healthcare (NASDAQ:DH) and Zenvia (NASDAQ:ZENV)

Reviewing Definitive Healthcare (NASDAQ:DH) and Zenvia (NASDAQ:ZENV)

评论Fulitive Healthcare(纳斯达克:WHO)和Zenvia(纳斯达克:ZENV)
Defense World ·  2023/01/02 02:11

Definitive Healthcare (NASDAQ:DH – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

确定医疗(纳斯达克:HD-GET评级)和捷维亚(纳斯达克:ZENV-GET评级)都是小盘医疗公司,但哪一项投资更具优势?我们将根据两家公司的估值、收益、机构持股、分析师建议、盈利能力、股息和风险等方面的实力进行比较。

Risk and Volatility

风险和波动性

Definitive Healthcare has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, Zenvia has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500.

Definitive Healthcare的贝塔系数为0.4,这意味着其股价的波动性比标准普尔500指数低60%。相比之下,Zenvia的贝塔系数为1.56,这意味着其股价的波动性比标准普尔500指数高56%。

Get
到达
Definitive Healthcare
权威医疗保健
alerts:
警报:

Profitability

盈利能力

This table compares Definitive Healthcare and Zenvia's net margins, return on equity and return on assets.

此表比较了Desitive Healthcare和Zenvia的净利润率、股本回报率和资产回报率。

Net Margins Return on Equity Return on Assets
Definitive Healthcare -12.56% 0.69% 0.49%
Zenvia -5.59% -3.71% -2.36%
净利润率 股本回报率 资产回报率
权威医疗保健 -12.56% 0.69% 0.49%
Zenvia -5.59% -3.71% -2.36%

Institutional and Insider Ownership

机构和内部人持股

35.7% of Zenvia shares are held by institutional investors. 17.5% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Zenvia 35.7%的股份由机构投资者持有。17.5%的最终医疗股份由公司内部人士持有。强大的机构持股表明,对冲基金、捐赠基金和大型基金管理公司相信,一家公司有望实现长期增长。

Earnings & Valuation

收益与估值

This table compares Definitive Healthcare and Zenvia's gross revenue, earnings per share and valuation.

此表比较了Definitive Healthcare和Zenvia的毛收入、每股收益和估值。

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Definitive Healthcare $166.15 million 6.95 -$51.02 million ($0.27) -40.70
Zenvia $113.49 million 0.42 -$8.27 million ($0.25) -4.60
总收入 价格/销售额比 净收入 每股收益 市盈率
权威医疗保健 1.6615亿美元 6.95 -5,102万元 ($0.27) -40.70
Zenvia 1.1349亿美元 0.42 -827万元 ($0.25) -4.60

Zenvia has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Zenvia, indicating that it is currently the more affordable of the two stocks.

与Defintive Healthcare相比,Zenvia的收入较低,但收益较高。最终医疗保健的市盈率低于Zenvia,这表明它目前是两只股票中更负担得起的一只。

Analyst Ratings

分析师评级

This is a summary of current recommendations and price targets for Definitive Healthcare and Zenvia, as provided by MarketBeat.com.

这是由MarketBeat.com提供的对Finitive Healthcare和Zenvia的当前建议和价格目标的摘要。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare 0 5 4 0 2.44
Zenvia 0 4 0 0 2.00
销售评级 保持评级 购买评级 强劲的买入评级 评级分数
权威医疗保健 0 5 4 0 2.44
Zenvia 0 4 0 0 2.00

Definitive Healthcare currently has a consensus target price of $19.11, suggesting a potential upside of 73.90%. Zenvia has a consensus target price of $2.63, suggesting a potential upside of 128.26%. Given Zenvia's higher possible upside, analysts clearly believe Zenvia is more favorable than Definitive Healthcare.

最终医疗保健目前的共识目标价为19.11美元,暗示潜在上行空间为73.90%。Zenvia的一致目标价为2.63美元,暗示潜在上涨128.26%。考虑到Zenvia更有可能的上行空间,分析师们显然认为Zenvia比Definitive Healthcare更有利。

About Definitive Healthcare

关于终极医疗保健

(Get Rating)

(获取评级)

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Finitive Healthcare Corp.及其子公司在美国提供医疗保健商业情报。其解决方案提供有关医疗保健提供者及其活动的信息,以帮助该领域的客户,范围从产品开发到上市规划,以及销售和营销执行。该公司的平台提供16个智能模块,涵盖销售、营销、临床研究和产品开发、战略、人才获取和医生网络管理等功能领域。它为生物制药和医疗器械公司、医疗保健信息技术公司和医疗保健提供者提供服务;以及其他多元化公司,包括医疗保健生态系统中的人员和商业房地产公司、金融机构和其他组织。Finitive Healthcare Corp.成立于2011年,总部设在马萨诸塞州弗雷明翰。

About Zenvia

关于Zenvia

(Get Rating)

(获取评级)

Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.

Zenvia Inc.提供客户体验交流平台,使企业能够为其最终客户在其生命周期中跨越一系列B2C垂直市场创造独特的旅程。Zenvia Inc.的总部设在圣保罗。

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

获得权威医疗日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对最终医疗保健及相关公司的评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发